Related Experiment Video
Updated: Jun 21, 2026

06:33
Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
The EEG in hypnosedative drug withdrawal and dependence
European Archives of Psychiatry and Neurological Sciences
|January 1, 1984
Summary
Compulsive hypnosedative drug use leads to tolerance and dependence. This study explores electroclinical correlations in patients with hypnosedative withdrawal syndrome, suggesting it
Area of Science:
- Neuroscience
- Clinical Neurology
- Pharmacology
Background:
- Compulsive hypnosedative drug use frequently causes tolerance and physical dependence.
- Clinical electroclinical correlations in hypnosedative drug withdrawal are not well-documented.
- Existing data primarily stem from human and animal experimental models.
Purpose of the Study:
- To investigate electroclinical correlations in patients experiencing hypnosedative drug withdrawal.
- To relate clinical and EEG dysfunction to the neurochemical theory of drug dependence and withdrawal.
- To explore the physiopathogenesis of withdrawal symptoms at a neuronal level.
Main Methods:
- Analysis of electroencephalogram (EEG) features in 22 patients with hypnosedative drug withdrawal.
- Correlation of EEG findings with clinical signs of withdrawal syndrome (minor/major).
- Integration of neurochemical theories of dependence to explain observed dysfunctions.
Main Results:
- EEG features provide informative value in assessing hypnosedative drug withdrawal.
- Electroclinical correlations were investigated in the clinical setting.
- Withdrawal syndrome is linked to transient metabolic imbalance at the neuronal level.
Conclusions:
- Hypnosedative drug withdrawal syndrome may be considered a form of metabolic encephalopathy.
- The severity and onset of this encephalopathy are influenced by exogenous and personal factors.
- Understanding these electroclinical correlations aids in managing withdrawal and its neurological impact.
More Related Videos
Related Concept Videos
Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

